Investor Alert: a Class Action Has Been Filed Against MiMedx Group, Inc.; Investors Encouraged to Inquire About Their Legal Rights
ATLANTA, GA--(Marketwired - Sep 16, 2013) - Holzer Holzer & Fistel, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG) securities between March 15, 2013 and September 4, 2013. The complaint alleges that a series of statements made during that time regarding MiMedx's business, operations and prospects were false and misleading. Specifically, the complaint alleges that MiMedx misled investors as to whether its amniotic/chorionic-based products required FDA approval. On September 4, 2013, MiMedx confirmed that it received a letter from the FDA claiming that its Surgical Biologics unit was in violation of the Public Health Service Act due to the Company's manufacturing and marketing of certain of its products without required licenses.
If you purchased MiMedx common stock between March 15, 2013 and September 4, 2013, or if you are a long time holder of Company stock, and have questions concerning your legal rights, you are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.
Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.
